We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
P&G (PG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Read MoreHide Full Article
Wall Street analysts expect Procter & Gamble (PG - Free Report) to post quarterly earnings of $1.43 per share in its upcoming report, which indicates a year-over-year increase of 2.1%. Revenues are expected to be $20.82 billion, up 1.4% from the year-ago quarter.
The current level reflects a downward revision of 0.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Bearing this in mind, let's now explore the average estimates of specific P&G metrics that are commonly monitored and projected by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Net sales- Beauty' of $3.77 billion. The estimate suggests a change of +1.1% year over year.
Analysts' assessment points toward 'Net sales- Grooming' reaching $1.69 billion. The estimate indicates a year-over-year change of +2%.
The combined assessment of analysts suggests that 'Net sales- Corporate' will likely reach $186.14 million. The estimate points to a change of -7.9% from the year-ago quarter.
The consensus estimate for 'Net sales- Fabric & Home Care' stands at $7.37 billion. The estimate indicates a year-over-year change of +1.4%.
It is projected by analysts that the 'Net sales- Baby, Feminine & Family Care' will reach $5.02 billion. The estimate indicates a change of +0.1% from the prior-year quarter.
According to the collective judgment of analysts, 'Net sales- Health Care' should come in at $2.74 billion. The estimate points to a change of +2.7% from the year-ago quarter.
Analysts expect 'Organic Sales Growth (YoY change) - Beauty' to come in at 1.8%. Compared to the present estimate, the company reported 3.0% in the same quarter last year.
Analysts forecast 'Organic Sales Growth (YoY change) - Grooming' to reach 3.2%. Compared to the current estimate, the company reported 7.0% in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Organic Sales Growth (YoY change) - Health Care' should arrive at 3.2%. Compared to the present estimate, the company reported 4.0% in the same quarter last year.
The average prediction of analysts places 'Earnings before income taxes- Beauty' at $767.63 million. The estimate compares to the year-ago value of $690.00 million.
Analysts predict that the 'Earnings before income taxes- Grooming' will reach $429.38 million. The estimate compares to the year-ago value of $395.00 million.
The consensus among analysts is that 'Earnings before income taxes- Health Care' will reach $454.46 million. Compared to the present estimate, the company reported $433.00 million in the same quarter last year.
Over the past month, P&G shares have recorded returns of -0.4% versus the Zacks S&P 500 composite's +5.7% change. Based on its Zacks Rank #3 (Hold), PG will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
P&G (PG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Wall Street analysts expect Procter & Gamble (PG - Free Report) to post quarterly earnings of $1.43 per share in its upcoming report, which indicates a year-over-year increase of 2.1%. Revenues are expected to be $20.82 billion, up 1.4% from the year-ago quarter.
The current level reflects a downward revision of 0.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Bearing this in mind, let's now explore the average estimates of specific P&G metrics that are commonly monitored and projected by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Net sales- Beauty' of $3.77 billion. The estimate suggests a change of +1.1% year over year.
Analysts' assessment points toward 'Net sales- Grooming' reaching $1.69 billion. The estimate indicates a year-over-year change of +2%.
The combined assessment of analysts suggests that 'Net sales- Corporate' will likely reach $186.14 million. The estimate points to a change of -7.9% from the year-ago quarter.
The consensus estimate for 'Net sales- Fabric & Home Care' stands at $7.37 billion. The estimate indicates a year-over-year change of +1.4%.
It is projected by analysts that the 'Net sales- Baby, Feminine & Family Care' will reach $5.02 billion. The estimate indicates a change of +0.1% from the prior-year quarter.
According to the collective judgment of analysts, 'Net sales- Health Care' should come in at $2.74 billion. The estimate points to a change of +2.7% from the year-ago quarter.
Analysts expect 'Organic Sales Growth (YoY change) - Beauty' to come in at 1.8%. Compared to the present estimate, the company reported 3.0% in the same quarter last year.
Analysts forecast 'Organic Sales Growth (YoY change) - Grooming' to reach 3.2%. Compared to the current estimate, the company reported 7.0% in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Organic Sales Growth (YoY change) - Health Care' should arrive at 3.2%. Compared to the present estimate, the company reported 4.0% in the same quarter last year.
The average prediction of analysts places 'Earnings before income taxes- Beauty' at $767.63 million. The estimate compares to the year-ago value of $690.00 million.
Analysts predict that the 'Earnings before income taxes- Grooming' will reach $429.38 million. The estimate compares to the year-ago value of $395.00 million.
The consensus among analysts is that 'Earnings before income taxes- Health Care' will reach $454.46 million. Compared to the present estimate, the company reported $433.00 million in the same quarter last year.
View all Key Company Metrics for P&G here>>>Over the past month, P&G shares have recorded returns of -0.4% versus the Zacks S&P 500 composite's +5.7% change. Based on its Zacks Rank #3 (Hold), PG will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .